The company's platform develops an ultra-affinity antibody discovery engine and has a pipeline of protein products in development. Revolve addresses the problem of generating and screening vast mutational sequence space with its patented library generation platform, producing custom DNA libraries with unparalleled efficiency. This technology enables healthcare researchers to create high-affinity antibodies for diagnostic and therapeutic applications, oncolytic cancer therapeutics, and infrared fluorescent proteins for live deep-tissue imaging.